Stryker Revenue

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Revenue Analysis

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.
Stryker 
Revenue 
 = 
Money Received 
Discounts and Returns 
 = 
3.01 B

Distress Driver Correlations

 Stryker Revenues 
Benchmark  Embed    Timeline 

About Revenue

Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Compare to competition

Stryker Revenue Assessment

Margin

Stryker Margin Growth Rates
Operating Margin
EBITDA Margin
Gross Margin
Based on latest financial disclosure Stryker Corporation reported 3.01 B of revenue. This is 53.67% lower than that of the Healthcare sector, and significantly higher than that of Medical Equipment industry, The Revenue for all stocks is 69.41% higher than the company.

Peer Comparison

Stryker Revenue Comparison
  Revenue 
Benchmark  Embed    Stryker Comparables 
Stryker is currently under evaluation in revenue category among related companies.

Did you try this?

Run Chance of Distress Now
   

Chance of Distress

Get analysis of equity chance of financial distress in the next 2 years
Hide  View All  Next  Launch Chance of Distress
Return On Equity0.19 %
Return On Asset0.09 %
Profit Margin0.15 %
Operating Margin22.65 %
Current Valuation13.87 B
Shares Outstanding395.92 M
Shares Owned by Insiders8.29 %
Shares Owned by Institutions76.00 %
Number of Shares Shorted8.87 M
Price to Earning27.97 times
Price to Book4.95 times
Price to Sales4.24 times
Revenue3.01 B
Gross Profit1.9 B
EBITDA3.11 B
Net Income345.6 M
Cash and Equivalents37.8 M
Cash per Share8.07 times
Total Debt501.7 M
Debt to Equity0.73 times
Current Ratio2.43 times
Book Value Per Share25.49 times
Cash Flow from Operations516.2 M
Short Ratio7.44 times
Earnings Per Share4.39 times
Price to Earnings To Growth2.12 times
Number of Employees27 K
Beta0.53
Market Capitalization13.29 B
Total Asset2.82 B
Retained Earnings8.84 B
Working Capital443.8 M
Current Asset1.15 B
Current Liabilities707.5 M
Z Score24.1